Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05312671
Title Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

bladder small cell carcinoma

urinary bladder small cell neuroendocrine carcinoma

Therapies

Atezolizumab + Carboplatin + Etoposide

Atezolizumab + Cisplatin + Etoposide

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.